1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Growth Failure: new trials by email Literature Review of Growth Failure trials Research Report on Growth Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1 Increlex - Growth Failure, X-linked Severe Combined Immunodeficiency (XSCID) | Phase 1 / Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 6 | 2007-06-01 | 2015-07-03 |
Failure to Thrive (1) · X-Linked Combined Immunodeficiency Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infant, Newborn, Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Primary Immunodeficiency Diseases (1) · Severe Combined Immunodeficiency (1) · Signs and Symptoms (1)
mecasermin (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (1)